Filing Details

Accession Number:
0001415889-21-003610
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-15 19:17:52
Reporting Period:
2021-07-13
Accepted Time:
2021-07-15 19:17:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646382 Matthew Rabinowitz C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Executive Chairman No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-13 307 $0.00 580,202 No 4 M Direct
Common Stock Disposition 2021-07-14 76 $116.20 580,126 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-07-13 307 $0.00 307 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
921 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 613,496 Indirect Matthew Rabinowitz Grantor Retained Annuity Trust
Common Stock 40,000 Indirect RMDM Trust
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting April 13, 2019.
  2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  3. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
  4. The RSUs vest over four years. 25% of the RSUs vested on April 13, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.